Streetbeat News

Stock Prices

AMZN

The analysis compares Amazon.com (AMZN) against its competitors in the Broadline Retail industry, highlighting its financial metrics, market position, and growth prospects. Amazon is shown to be overvalued based on PE, PB, and PS ratios compared to industry averages, with a lower ROE and substantial decline in revenue growth. However, it has a favorable debt-to-equity ratio and exhibits strong profitability with higher EBITDA and gross profit.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 3:00 pm

BIGC

Analyst opinions on BigCommerce Holdings (NASDAQ:BIGC) vary, with recent ratings showing a shift towards a more bullish outlook. The average 12-month price target is now $9.08, down from $10.40, indicating a 12.69% decrease. Analysts from firms like Needham, Morgan Stanley, and Barclays have adjusted their price targets and ratings, reflecting changes in market conditions and company performance. BigCommerce's financials show positive revenue growth but challenges in market capitalization, net margin, and debt management.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 3:00 pm

ONTO

Onto Innovation (NYSE:ONTO) has received mixed analyst ratings over the past three months, with a recent shift towards more bullish sentiments. The average 12-month price target has been raised to $233.33, indicating a 10.32% increase from the previous target. Analysts from B. Riley Securities, Evercore ISI Group, and Stifel have adjusted their ratings and price targets, reflecting optimism about the company's performance. Despite facing a revenue decline of -13.59% in the last quarter of 2023, Onto Innovation maintains a strong net margin and ROA, outperforming industry averages.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 3:00 pm

NVDA

The article provides an in-depth analysis of NVIDIA's financial and market position within the Semiconductors & Semiconductor Equipment industry, comparing it with its competitors. It highlights NVIDIA's high valuation metrics such as P/E, P/B, and P/S ratios, which suggest a potential overvaluation. However, NVIDIA's operational performance, including ROE, EBITDA, gross profit, and revenue growth, indicates strong financial health and growth prospects. The analysis also notes NVIDIA's lower debt-to-equity ratio compared to its top four peers, suggesting a strong financial position with less reliance on debt financing.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 3:00 pm

SYRE

BTIG analyst Julian Harrison has maintained a Buy rating on Spyre Therapeutics (NASDAQ:SYRE) and increased the price target from $32 to $40.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 2:54 pm

LIDR

AEye Inc (NASDAQ:LIDR) shares surged 75% to $2.06 after announcing a partnership with LITEON Technology Corporation to supply 4Sight™-based lidar products to automotive OEMs, leveraging LITEON's expertise in automotive electronics.

Portfolio Pulse from Henry Khederian

May 10, 2024 | 2:52 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo for May 10th, 2024, provides a trade strategy for SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA, based on a proprietary formula considering price, volume, and options flow. It offers detailed analysis for each asset, suggesting potential bullish and bearish price levels. Additionally, the memo highlights the importance of upcoming U.S. economic data releases and Federal Reserve members' speeches, advising traders to stay vigilant.

Portfolio Pulse from RIPS

May 10, 2024 | 2:51 pm

RBLX

Roblox Corp (RBLX) shares saw a slight recovery after a significant drop due to a weak outlook. Analysts from Goldman Sachs, Piper Sandler, and Wedbush have adjusted their price targets and ratings, reflecting concerns over the company's first-quarter performance and lowered full-year bookings guidance. Despite these adjustments, there is optimism about Roblox's long-term position in the gaming and interactive entertainment space, including its potential in the metaverse and creator economy.

Portfolio Pulse from Priya Nigam

May 10, 2024 | 2:50 pm

G

ITOS

NVAX

OUST

SG

Genpact Limited reported better-than-expected Q1 financial results, leading to a 6.8% rise in its shares. Other companies like Novavax, iTeos Therapeutics, and Sweetgreen also saw significant gains following positive financial results or strategic announcements. The overall market sentiment was positive, with the Dow Jones gaining over 100 points.

Portfolio Pulse from Avi Kapoor

May 10, 2024 | 2:48 pm

AEMD

BMY

MRK

Aethlon Medical Inc (NASDAQ:AEMD) announced positive results from an in vitro study of its Hemopurifier in removing extracellular vesicles from plasma, a key step ahead of its planned phase 1 oncology trials in Australia and India. The Hemopurifier aims to treat patients with solid tumors under anti-PD-1 monotherapy, including treatments like Merck & Co Inc's (NYSE:MRK) Keytruda and Bristol-Myers Squibb Co's (NYSE:BMY) Opdivo. AEMD shares rose 6.11% following the announcement.

Portfolio Pulse from Vandana Singh

May 10, 2024 | 2:46 pm